A Case of Sertoli-Leydig Cell Tumor.
- Author:
Young Seog CHO
1
;
Kyung Jae SHIN
;
Sang Myung KIM
;
Ki Hyun KIM
Author Information
1. Department of Obstetrics and Gynecology, Seoul Red Cross Hospital, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Sertoli-Leydig cell tumor;
Sex cord stromal cell tumor;
Vaginal bleeding
- MeSH:
Adolescent;
Female;
Humans;
Hysterectomy;
Lymph Node Excision;
Menopause;
Ovarian Neoplasms;
Ovary;
Prognosis;
Puberty;
Recurrence;
Sertoli-Leydig Cell Tumor*;
Survival Rate;
Uterine Hemorrhage
- From:Korean Journal of Obstetrics and Gynecology
2003;46(12):2524-2527
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The Sertoli-Leydig cell tumors belong to the group of sex-cord stromal tumors of the ovary. They account for less than 0.5% of all primary ovarian neoplasm. The majority of these tumors are benign and almost all are localized unilaterally. Sertoli-Leydig cell tumors occur predominantly in the second and third decades, rarely before puberty or after the menopause. In 40-50% of the patients, the presenting symptoms relate to clinical signs of androgenic activity. While most of the remainder are non-specific abdominal symptoms. Prognosis is generally favorable with 5-year survival rate of 70-90%. Recurrence is rare. Treatment varies with patient age, tumor stage, and differentiation from unilateral salpingo-oophorectomy and total hysterectomy concomitant with pelvic lymph node dissection. We have experienced a case of postmenopausal Sertoli-Leydig cell tumor with vaginal bleeding and so we present it with brief review of literature.
